Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tatsuo Nishioka"'
Autor:
Georgeta G. Trandafirescu, Masamichi Yamada, Tadao Orii, Jeffrey H. Grubb, Vu Chi Dung, Monica A. Gutierrez, Shunji Tomatsu, Amiko Ohashi, Yasuhiro Tosaka, Adriana M. Montaño, Hirotaka Oikawa, Mana Yamada, Tatsuo Nishioka
Publikováno v:
Molecular Genetics and Metabolism. 91:69-78
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The aims of this study were to establish Chinese hamster ovary (CHO) cells overexpressing recombinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a18a7174a602b46de0bdefdaa9bd781
https://doi.org/10.1016/j.ymgme.2007.01.004
https://doi.org/10.1016/j.ymgme.2007.01.004
Autor:
Patricia L.C. Lopez, Georgeta G. Trandafirescu, Shunji Tomatsu, Akihiko Noguchi, Matheus B. Vieira, Monica A. Gutierrez, Tatsuo Nishioka, Adriana M. Montaño, Tadao Orii, Hirotaka Oikawa
Publikováno v:
Molecular Genetics and Metabolism. 89:139-149
Design of efficient treatment strategies for diseases requires clarification of the nature of each mutation causing the disease. In this study, we have investigated three factors to correctly predict the correlation between genotype and phenotype on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4904e1bbdcec8e175e127e5b85b2b44
https://doi.org/10.1016/j.ymgme.2006.05.012
https://doi.org/10.1016/j.ymgme.2006.05.012
Autor:
William S. Sly, Georgeta G. Trandafirescu, Roseline Froissart, Shunji Tomatsu, Alan Cooper, Paola Di Natale, Seiji Yamaguchi, Monica A. Gutierrez, Kazuko Sukegawa, Tadao Orii, Akihiko Noguchi, Irène Maire, Tatsuo Nishioka, Amparo Chabas, Andreas Gal
Publikováno v:
European Journal of Human Genetics. 14:838-845
Hunter syndrome, an X-linked disorder, results from deficiency of iduronate-2-sulfatase (IDS). Around 40% of independent point mutations at IDS were found at CpG sites as transitional events. The 15 CpG sites in the coding sequences of exons 1 and 2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f308529b0333c0ec05c4376393f32c21
https://doi.org/10.1038/sj.ejhg.5201615
https://doi.org/10.1038/sj.ejhg.5201615
Autor:
Naoki Sakura, Kayo Yamoto, Tatsuo Nishioka, Ken-ichi Miyamoto, Katsuhiro Toshima, Koichi Yokogawa
Publikováno v:
Biological and Pharmaceutical Bulletin. 29:1229-1233
金沢大学医学部附属病院薬剤部
We examined the usefulness of intranasal (i.n.) administration of a novel osteotropic prodrug of estradiol, estradiol-17β-succinate-(L-aspartate) 6 (E2·17D6), for selective drug delivery to bone. E2·
We examined the usefulness of intranasal (i.n.) administration of a novel osteotropic prodrug of estradiol, estradiol-17β-succinate-(L-aspartate) 6 (E2·17D6), for selective drug delivery to bone. E2·
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ecac1fbac40d59f65400118186652e
https://doi.org/10.1248/bpb.29.1229
https://doi.org/10.1248/bpb.29.1229
Autor:
Tadao Orii, Shunji Tomatsu, Olga M. Pena, Patricia Palomo López, Seiji Yamaguchi, Adriana M. Montaño, Tatsuo Nishioka, Akihiko Noguchi, Monica A. Gutierrez, Georgeta G. Tranda firescu
Publikováno v:
Human Mutation. 26:500-512
Mucopolysaccharidosis IVA (MPS IVA; Morquio A disease) is an autosomal-recessive disorder caused by a deficiency of lysosomal N-acetylgalactosamine-6-sulfate sulfatase (GALNS; E.C.3.1.6.4). GALNS is required to degrade glycosaminoglycans, keratan sul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840a25206f63608749dbbbf1e217427f
https://doi.org/10.1002/humu.20257
https://doi.org/10.1002/humu.20257
Autor:
Monica A. Gutierrez, Matheus B. Vieira, Yasuhiro Tosaka, Tatsuo Nishioka, Akihiko Noguchi, Olga M. Pena, Mana Yamada, Masamichi Yamada, Seiji Yamaguchi, Tadao Orii, Koji O. Orii, Shunji Tomatsu, Georgeta G. Trandafirescu, Adriana M. Montaño, Jeffrey H. Grubb, Leticia Laybauer
Publikováno v:
Human Molecular Genetics. 14:3321-3335
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disease caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) deficiency. In recent studies of enzyme replacement therapy for animal models with lysosomal storage diseases, cellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f629cf49b7ec864dd6d58db68f25d4
https://doi.org/10.1093/hmg/ddi364
https://doi.org/10.1093/hmg/ddi364
Autor:
Piedad Sarmient, Tatiana Dieter, Adriana M. Montaño, Luis A. Barrera, Ida Vanessa Doederlein Schwartz, Raquel Dodelson de Kremer, Tatsuo Nishioka, Olga Peña Serrato, Norberto Guelbert, Seiji Yamaguchi, Roberto Giugliani, Shunji Tomatsu, Akihiko Noguchi, Monica A. Gutierrez, Gabriela M. Repetto
Publikováno v:
Journal of Human Genetics. 49:490-494
Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Mutation screening of the GALNS was performed by genomic PCR and direct sequence analyses in 20 MPS IVA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a695676f691e2e1cacfdd5bacd1e4d57
https://doi.org/10.1007/s10038-004-0178-8
https://doi.org/10.1007/s10038-004-0178-8
Autor:
Eiji Ochiai, Koichi Yokogawa, Kazuyo Fukushima, Shuzo Moritani, Masaaki Nomura, Tatsuo Nishioka, Ken-ichi Miyamoto, Hideomi Yamagami, Shohei Kasugai
Publikováno v:
Biochemical Pharmacology. 66:801-807
We examined the effect of a phosphodiesterase 4 (PDE4) inhibitor, 3,4-dipropyl-4,5,7,8-tetrahydro-3 H -imidazo[1,2- i ]-purin-5-one (XT-611) on osteoclast formation in three different mouse bone-marrow cell (BMC) culture systems. We confirmed that se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83fa28152a8f971be332348faee09581
https://doi.org/10.1016/s0006-2952(03)00409-x
https://doi.org/10.1016/s0006-2952(03)00409-x
Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice
Autor:
Amiko Ohashi, Toshihiro Oguma, Carole Vogler, Yun Tan, Vu Chi Dung, Tatsuo Nishioka, Monica A. Gutierrez, Hirotaka Oikawa, Yukio Yoneda, Ken-ichi Miyamoto, Tadao Orii, William S. Sly, Shunji Tomatsu, Jeffrey H. Grubb, Adriana M. Montaño
Publikováno v:
Molecular genetics and metabolism. 94(2)
We have tested an acidic oligopeptide-based targeting system for delivery of enzymes to tissues, especially bone and brain, in a murine mucopolysaccharidosis type VII (MPS VII) model. This strategy is based upon tagging a short peptide consisting of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4eb2e17caf064cfb33d58e7f14135c
https://pubmed.ncbi.nlm.nih.gov/18359257
https://pubmed.ncbi.nlm.nih.gov/18359257
Autor:
Seiji Nakamura, Masaaki Nomura, Shinjiro Kobayashi, Daisuke Ichimatsu, Ken-ichi Miyamoto, Tatsuo Nishioka, Shuzo Moritani, Koichi Yokogawa
Publikováno v:
Molecular carcinogenesis. 46(6)
金沢大学医学部附属病院薬剤部
We found that quercetin, myricetin, quercetagetin, fisetin, (-)-epigallocatechin gallate (EGCG), and theaflavins, among 24 flavonoids examined, markedly inhibited epidermal growth factor (EGF)-induced c
We found that quercetin, myricetin, quercetagetin, fisetin, (-)-epigallocatechin gallate (EGCG), and theaflavins, among 24 flavonoids examined, markedly inhibited epidermal growth factor (EGF)-induced c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38175e1e2efc9728c8be8cea725171cc
https://pubmed.ncbi.nlm.nih.gov/17219438
https://pubmed.ncbi.nlm.nih.gov/17219438